Search research articles
Contact Us
Filters
Showing results (41-50 of 323) with videos related to
Page
of 33
Sort By:
Lancet (London, England)
|
April 27, 2016
Gout
Nicola Dalbeth, Tony R Merriman, Lisa K Stamp
Internal Medicine Journal
|
March 29, 2007
Emerging therapies in the long-term management of hyperuricaemia and gout
L K Stamp, J L O'Donnell, P T Chapman
The Journal of Rheumatology
|
July 2, 2004
Paracrine upregulation of monocyte cyclooxygenase-2 by mediators produced by T lymphocytes: role of interleukin 17 and interferon-gamma
Lisa K Stamp, Michael J James, Leslie G Cleland
Seminars in Arthritis and Rheumatism
|
October 1, 2005
Diet and rheumatoid arthritis: a review of the literature
Lisa K Stamp, Michael J James, Leslie G Cleland
Therapeutic Advances in Musculoskeletal Disease
|
August 28, 2025
The genetics of gout: translation into clinical practice
Tony R Merriman, Fiorella Rosas-Chavez, Lisa K Stamp
The Journal of Rheumatology
|
July 2, 2004
Upregulation of synoviocyte COX-2 through interactions with T lymphocytes: role of interleukin 17 and tumor necrosis factor-alpha
Lisa K Stamp, Leslie G Cleland, Michael J James
The Lancet. Rheumatology
|
January 17, 2024
Making the right thing the easy thing to do: strategies to improve outcomes in gout
Nicola Dalbeth, Susan Reid, Lisa K Stamp, et al.
Joint Bone Spine
|
October 11, 2015
Allopurinol and kidney function: An update
Lisa K Stamp, Peter T Chapman, Suetonia C Palmer
Expert Opinion on Emerging Drugs
|
September 25, 2018
Expert opinion on emerging urate-lowering therapies
Lisa K Stamp, Tony R Merriman, Jasvinder A Singh
British Journal of Clinical Pharmacology
|
November 14, 2018
Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!
Lisa K Stamp, Daniel F B Wright, Nicola Dalbeth
Page
of 33
Search research articles
Search
Showing results (41-50 of 323) with videos related to
Sort By:
Page
of 33
Lancet (London, England)
|
April 27, 2016
Gout
Nicola Dalbeth, Tony R Merriman, Lisa K Stamp
Internal Medicine Journal
|
March 29, 2007
Emerging therapies in the long-term management of hyperuricaemia and gout
L K Stamp, J L O'Donnell, P T Chapman
The Journal of Rheumatology
|
July 2, 2004
Paracrine upregulation of monocyte cyclooxygenase-2 by mediators produced by T lymphocytes: role of interleukin 17 and interferon-gamma
Lisa K Stamp, Michael J James, Leslie G Cleland
Seminars in Arthritis and Rheumatism
|
October 1, 2005
Diet and rheumatoid arthritis: a review of the literature
Lisa K Stamp, Michael J James, Leslie G Cleland
Therapeutic Advances in Musculoskeletal Disease
|
August 28, 2025
The genetics of gout: translation into clinical practice
Tony R Merriman, Fiorella Rosas-Chavez, Lisa K Stamp
The Journal of Rheumatology
|
July 2, 2004
Upregulation of synoviocyte COX-2 through interactions with T lymphocytes: role of interleukin 17 and tumor necrosis factor-alpha
Lisa K Stamp, Leslie G Cleland, Michael J James
The Lancet. Rheumatology
|
January 17, 2024
Making the right thing the easy thing to do: strategies to improve outcomes in gout
Nicola Dalbeth, Susan Reid, Lisa K Stamp, et al.
Joint Bone Spine
|
October 11, 2015
Allopurinol and kidney function: An update
Lisa K Stamp, Peter T Chapman, Suetonia C Palmer
Expert Opinion on Emerging Drugs
|
September 25, 2018
Expert opinion on emerging urate-lowering therapies
Lisa K Stamp, Tony R Merriman, Jasvinder A Singh
British Journal of Clinical Pharmacology
|
November 14, 2018
Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!
Lisa K Stamp, Daniel F B Wright, Nicola Dalbeth
Page
of 33